COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 452: Articles 4511-4520  | Next

Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 that Exhibits Antiviral Efficacy in SARS-CoV-2 Infected African Green Monkeys
Mackman, R. L., Kalla, R., Babusis, D., Pitts, J., Barrett, K. T., Chun, K., Du Pont, V., Rodriguez, L., Moshiri, J., Xu, Y., Lee, M., Lee, G., Bleier, B., Nguyen, A.-Q., O'Keefe, B. M., Ambrosi, A., Cook, M., Yu, J., Dempah, K. E., Bunyan, E., Riola, N. C., Lu, X., Liu, R., Davie, A., Hsiang, T.-Y., Gale, M., Niedziela-Majka, A., Feng, J. Y., Hedskog, C., Bilello, J. P., Subramanian, R., Cihlar, T.
10.1101/2023.04.28.538473 — Posted: 2023-04-28
Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID-19 patients with pre-existing co-morbidities
Madera-Sandoval, R. L., Cerbulo-Vazquez, A., Arriaga-Pizano, L. A., Cabrera-Rivera, G. L., Basilio-Galveza, E., Miranda-Cruz, P. E., Garcia de la Rosa, M. T., Prieto-Chavez, J. L., Rivero-Arredondo, S. V., Cruz-Cruz, A., Rodriguez-Hernandez, D., Salazar-Rios, M. E., Salazar-Rios, E., Serrano-Molina, E. D., De Lira-Barraza, R. C., Villanueva-Compean, A. H., Esquivel-Pineda, A., Ramirez-Montes de Oca, R., Unzueta-Marta, O., Flores-Padilla, G., Anda-Garay, J. C., Sanchez-Hurtado, L. A., Calleja-Alarcon, S., Romero-Gutierrez, L., Torres-Rosas, R., Bonifaz, L. C., Pelayo, R., Marquez-Marquez, E., L
10.1101/2023.04.25.23288937 — Posted: 2023-04-27
The impact of long-term conditions and comorbidity patterns on COVID-19 infection and hospitalisation: a cohort study
Huang, Y.-T., Steptoe, A., Patel, R., Fuller-Thomson, E., Cadar, D.
10.1101/2023.04.25.23289035 — Posted: 2023-04-27
Stent For Life Initiative in Portugal: progress through years and Covid-19 Impact
Pereira, E., Cale, R., Pereira, A. M., Pereira, H., Martins, L. D.
10.1101/2023.04.25.23288494 — Posted: 2023-04-27
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift
Song, G., Yuan, M., Liu, H., Capozzola, T., Lin, R. N., Torres, J. L., He, W.-t., Musharrafieh, R., Dueker, K., Zhou, P., Callaghan, S., Mishra, N., Yong, P., Anzanello, F., Avillion, G., Vo, A. L., Li, X., Makhdoomi, M., Feng, Z., Zhu, X., Peng, L., Nemazee, D., Safonova, Y., Briney, B., Ward, A. B., Burton, D. R., Wilson, I. A., Andrabi, R.
10.1101/2023.04.26.538488 — Posted: 2023-04-27
Designer DNA NanoGripper
Zhou, L., Xiong, Y., Cooper, L., Shepherd, S., Song, T., Dwivedy, A., Rong, L., Wang, T., Cunningham, B., Wang, X.
10.1101/2023.04.26.538490 — Posted: 2023-04-27
Immune signature of patients with cardiovascular disease - in-depth immunophenotyping predicts increased risk for a severe course of COVID-19
Guenter, M., Mueller, K. A. L., Salazar, M. J., Gekeler, S., Prang, C., Harm, T., Gawaz, M., Autenrieth, S. E.
10.1101/2023.04.24.23288921 — Posted: 2023-04-26
Aerosol Jet Printing Enabled Dual-Function Electrochemical and Colorimetric Biosensor for SARS-CoV-2 Detection
Liu, L., Xu, Z., Molina Vargas, A. M., Dollery, S., Schrlau, M., Cormier, D., O'Connell, M., Tobin, G., Du, K.
10.1101/2023.04.20.23288904 — Posted: 2023-04-26
Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway
Al-Hakeim, H., Abed, A. K., Almulla, A. F., Moustafa, S. R., Maes, M. F.
10.1101/2023.04.24.23288115 — Posted: 2023-04-26
Is Covid-19 Mortality "Like the Flu"? A Cumulative Death Rates Comparison
Wrigley-Field, E., Himmelstern, J.
10.1101/2023.04.24.23289045 — Posted: 2023-04-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).